A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)

NCT01219933 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: methylprednisolone
DRUG: tocilizumab [RoActemra/Actemra]

Sponsor

Hoffmann-La Roche